Hence, Merve Sen et al. used magnetic NPs (MNPs) and magnetic forces to deliver valosin-containing protein (VCP) siRNA into retinal explants to target VCP, the therapeutic target of autosomal-dominant retinitis pigmentosa (adRP). This evidence concerns the gene VCP and autosomal dominant retinitis pigmentosa.